PSA-1DCNN: Multimodal Biomarker and Text Integration for Lung Cancer Diagnosis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41770961.
- Also identified by DOI 10.1109/JBHI.2026.3669008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Integrating multimodal data, such as unstructured clinical narratives and quantitative blood biomarkers, remains a major challenge in modern healthcare due to heterogeneous formats, complex semantics, and limited inter-modal correlations. Despite significant advances in deep learning, effective fusion of clinical text and biomarkers is still unresolved, restricting the full potential of precision medicine. We propose PSA-1DCNN, a novel Parallel Self-Attention 1D Convolutional Neural Network designed for multimodal integration in lung cancer detection. By combining self-attention mechanisms with 1D convolutional layers, PSA-1DCNN captures global semantic relationships from clinical text while learning local discriminative patterns from biomarker data. We further investigate four fusion strategies to optimize cross-modal information integration. Experiments conducted on MIMIC-III and MIMIC-IV demonstrate that PSA-1DCNN outperforms state-of-the-art baselines, including ClinicalBERT, LSTM, and 1D-CNN. Our best-performing configuration achieves an F1-score of 98.4% on MIMIC-IV, with strong cross-version generalization to MIMIC-III. SHAP-based interpretability further highlights the clinical relevance of key biomarkers such as WBC and RBC, alongside critical textual features. This study presents a scalable and interpretable framework that bridges heterogeneous modalities, advancing precision oncology and offering promising opportunities for personalized diagnostics.